title: First localization and biochemical identification of chromogranin B- and secretoneurin-like immunoreactivity in the fetal human vagal/nucleus solitary complex.
abstract: The human vagal/nucleus solitary complex is a primary visceral relay station and an integrative brain stem area which displays a high density of chromogranin B- and secretoneurin-like immunoreactivity. In this study, we localized and biochemically identified these proteins during prenatal development. At prenatal week 11, 15, 20 and 37, we performed a chromatographic analysis to identify the molecular forms of PE-11, a peptide within the chromogranin B sequence, and secretoneurin, a peptide within secretogranin II. Their localization was studied with immunocytochemistry, and was compared to that of substance P which is well established as a functional neuropeptide in the vagal/nucleus solitary complex. At prenatal week 11, chromogranin B-, secretoneurin- and substance P-like immunoreactivities were detected consisting of varicosities, varicose fibers and single cells. At the same time, PE-11 and secretoneurin appeared as a single peak in chromatographic analysis. Prohormone convertases PC1- and PC2-like immunoreactivities were also present at week 11. In general, the density for each peptide increased during later fetal stages with the highest density at week 37. These results demonstrate that each chromogranin peptide is expressed during human fetal life in neurons of the vagal/nucleus solitary complex indicating that these peptides could be important during prenatal development.
authors.affiliation: Department of Otolaryngology, Medical University of Innsbruck, A-6020 Innsbruck, Austria.
authors.forename: M
authors.initials: M
authors.lastname: Bitsche
authors.forename: A
authors.initials: A
authors.lastname: Schrott-Fischer
authors.forename: J
authors.initials: J
authors.lastname: Hinterhoelzl
authors.forename: R
authors.initials: R
authors.lastname: Fischer-Colbrie
authors.forename: C
authors.initials: C
authors.lastname: Sergi
authors.forename: R
authors.initials: R
authors.lastname: Glueckert
authors.forename: C
authors.initials: C
authors.lastname: Humpel
authors.forename: J
authors.initials: J
authors.lastname: Marksteiner
mesh_terms: D053378:Chromogranin B; D002864:Chromogranins / Q000032:analysis* / Q000502:physiology; D005260:Female; D005333:Fetus / Q000737:chemistry; D005865:Gestational Age; D006801:Humans; D007150:Immunohistochemistry; D008297:Male; D009479:Neuropeptides / Q000032:analysis*; D045664:Proprotein Convertase 1 / Q000032:analysis; D045706:Proprotein Convertase 2 / Q000032:analysis; D053381:Secretogranin II; D017552:Solitary Nucleus / Q000737:chemistry / Q000196:embryology*; D013373:Substance P / Q000032:analysis; D014630:Vagus Nerve / Q000737:chemistry / Q000196:embryology*
chemical_list: C506134:CHGB protein, human; D053378:Chromogranin B; D002864:Chromogranins; D009479:Neuropeptides; D053381:Secretogranin II; C081159:secretoneurin; D013373:Substance P; D045664:Proprotein Convertase 1; D045706:Proprotein Convertase 2